BMC Cancer

1. ZHU JY, Zhong Q, Yu JH, Wu D, et al
   Beyond TNM staging: validation of a CT-derived nutritional-inflammatory composite model (RFMmSIS) for prognostication in resectable gastric cancer.
   BMC Cancer. 2026;26:1067.
   

   >> Share

   
   

   
   Br J Cancer

2. HIRANO H, Yamada Y, Nagashima K, Hiraoka N, et al
   PD-L1 expression and survival in unresectable/recurrent gastric cancer treated by 1st-line treatment without immune checkpoint inhibitors: JCOG1013A1.
   Br J Cancer. 2026 Sep 4. doi: 10.1038/s41416-026-03607.
   

   >> Share

   
   

   
   Cancer Lett

3. LI Q, Yang J, Cao L, Wang Q, et al
   Cancer-associated fibroblast-enriched TAGLN orchestrates HGF/c-MET-dependent transcriptional reprogramming in gastric cancer.
   Cancer Lett. 2026;660:218832.
   

   >> Share

   
   
4. ZOU G, Yoshimura K, Fan Y, Zeng L, et al
   Pharmacologic inhibition of SOX9-CDK4 by CYD-4-61 impairs gastric adenocarcinoma growth and amplifies anti-PD-1 response.
   Cancer Lett. 2026;659:218777.
   

   >> Share

   
   

   
   Clin Res Hepatol Gastroenterol

5. AYARI M, Azouz SB, Jomni T
   Comment on "Sarcopenia status among treatment-naive gastric cancer patients in China: A cross-sectional study".
   Clin Res Hepatol Gastroenterol. 2026 Sep 12:102921.
   

   >> Share

   
   

   
   Dig Dis

6. JIA X, Wang X, Han X, Li M, et al
   The thirty years trends of gastric cancer attributable to smoking in China and Japan: Demographic decomposition and age-period-cohort analysis.
   Dig Dis. 2026 Sep 12:1. doi: 10.1159.
   

   >> Share

   
   

   
   Dig Dis Sci

7. ISLAM MS, Li D, Zhang J, Zheng Q, et al
   Comparison of Endoscopic Cap External Snare Resection (ECESR) and Endoscopic Muscularis Dissection (EMD) for Small Gastric Submucosal Tumors (
   Dig Dis Sci. 2026;71:4883-4893.
   

   >> Share

   
   

   
   Eur J Cancer

8. SHI CW, Singh A, Khosla AA, Thummalapalli R, et al
   Systemic therapies for gastroenteropancreatic neuroendocrine carcinomas: Current paradigm and future avenues.
   Eur J Cancer. 2026;246:117004.
   

   >> Share

   
   

   
   Oncology

9. SABATINI A, Bengala E, Picone V
   Biomarker-Oriented Contextual Analysis of First-Line Zolbetuximab and Immunotherapy-Based Strategies in HER2-Negative Metastatic Gastric Cancer.
   Oncology. 2026 Sep 9:1. doi: 10.1159.
   

   >> Share

   
   
10. BRODKIN J, Kaprio T, Mustonen H, Leppa A, et al
    CCL5, CLEC11A, IL-7, IL-8, and IL-13: Diagnostic serum biomarkers of gastric cancer identified in a 48-multiplex panel.
    Oncology. 2026 Sep 9:1. doi: 10.1159.
    

    >> Share

    
    

    
    World J Surg

11. NAGANO S, Kitadani J, Hayata K, Goda T, et al
    Hill Classification Predicts Postoperative Pneumonia After Minimally Invasive Distal Gastrectomy for Gastric Cancer.
    World J Surg. 2026 Sep 10. doi: 10.1002/wjs.70576.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share